SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection. Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutières syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response. We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64]”
From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This approach was necessary because PU.1 is the master transcriptional regulator necessary for macrophage differentiation and silencing PU.1 prior to infection results in a change in the cellular phenotype that causes resistance to HIV infection72,73.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
Manel, N., Hogstad, B., Wang, Y., Levy, D. E., Unutmaz, D., & Littman, D. R. (2010) · Nature · doi:10.1038/nature09337 · Cited by 427
Sobhian, B., Laguette, N., Yatim, A., Nakamura, M., Levy, Y., Kiernan, R., & Benkirane, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.012 · Cited by 381
Self-citationBlanchet, F. P., Moris, A., Nikolic, D. S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.011 · Cited by 295
Self-citationImmunoaffinity Purification of Mammalian Protein Complexes
Nakatani, Y., & Ogryzko, V. (2003) · Methods in Enzymology · doi:10.1016/s0076-6879(03)70037-8 · Cited by 283
DCs and NK cells: critical effectors in the immune response to HIV-1
Altfeld, M., Fadda, L., Frleta, D., & Bhardwaj, N. (2011) · Nature Reviews Immunology · doi:10.1038/nri2935 · Cited by 216
Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000059 · Cited by 209
Cited by
Items 501–600 of 1,001
Yu, C. H., Bhattacharya, A., Persaud, M., Taylor, A. B., Wang, Z., Bulnes‐Ramos, Á., Xu, J., Selyutina, A., Martínez‐López, A., Cano, K. E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21023-8 · Cited by 36
Han, M., Cantaloube-Ferrieu, V., Xie, M., Armani-Tourret, M., Woottum, M., Pagès, J., Colin, P., Lagane, B., & Bénichou, S. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010335 · Cited by 37
“Interestingly, it was also found that in vivo 582 infection of myeloid cells in infected animals occurred irrespective of expression of the SIV 583 Vpx auxiliary protein known to counteract the antiviral host cell restriction factor SAMHD1 584 highly expressed in myeloid cells [85-88].”
BackgroundMercier, S. K., Donaghy, H., Botting, R. A., Turville, S. G., Harman, A. N., Nasr, N., Ji, H. L., Kusebauch, U., Mendoza, L., Shteynberg, D. D., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003700 · Cited by 42
“Several HIV-1 restriction factors have been described for DCs, including the constitutively expressed APOBEC3G [34], SAMHD1 [35] and the HIV induced interferon stimulated genes [36].”
BackgroundInfluentialWei, W., Guo, H., Liu, X., Zhang, H., Qian, L., Luo, K., Markham, R. B., & Yu, X. (2013) · Journal of Virology · doi:10.1128/jvi.02568-13 · Cited by 39
HUSH, a Link Between Intrinsic Immunity and HIV Latency
Chougui, G., & Margottin-Goguet, F. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00224 · Cited by 40
“…protein 2 (BST2)/Tetherin (Neil et al., 2008; Van Damme et al., 2008), Sterile Alpha Motif domain and HD domain-containing protein 1 (SAMHD1) (Hrecka et al., 2011; Laguette et al., 2011) and Serine Incorporator 3 and 5 (Serinc3/5) (Matheson et al., 2015; Rosa et al., 2015; Usami et al., 2015).”
BackgroundInfluentialSAMHD1 Degradation Enhances Active Suppression of Dendritic Cell Maturation by HIV-1
Hertoghs, N., van der Aar, A. M. G., Setiawan, L. C., Kootstra, N. A., Gringhuis, S. I., & Geijtenbeek, T. B. H. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403016 · Cited by 40
“Recently it was suggested that SAMHD1 restricts HIV-1 replication in DCs and thereby prevents DC maturation (30, 33, 34, 44).”
BackgroundMethodInfluentialNoninfectious Retrovirus Particles Drive the Apobec3/Rfv3 Dependent Neutralizing Antibody Response
Smith, D. S., Guo, K., Barrett, B. S., Heilman, K. J., Evans, L. H., Hasenkrug, K. J., Greene, W. C., & Santiago, M. L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002284 · Cited by 34
“Most of these genes, such as TRIM5 a [1], Tetherin/Bst2 [2] and SAMHD1 [3], restrict retroviruses in the infected cell.”
HIV-derived vectors for therapy and vaccination against HIV
Nunzio, F. D., Félix, T., Arhel, N. J., Nisole, S., Charneau, P., & Beignon, A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.089 · Cited by 39
Innate Antiviral Response: Role in HIV-1 Infection
Pitha, P. M. (2011) · Viruses · doi:10.3390/v3071179 · Cited by 38
Cardinaud, S., Urrutia, A., Rouers, A., Coulon, P.-G. A., Kervevan, J., Richetta, C., Bet, A., Maze, E. A., Larsen, M., Iglesias, M. C., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646603 · Cited by 36
DDX3 in HIV-1 infection and sensing: A paradox
Stunnenberg, M., Geijtenbeek, T. B. H., & Gringhuis, S. I. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.03.001 · Cited by 36
CRISPR-Cas based targeting of host and viral genes as an antiviral strategy
Koujah, L., Shukla, D., & Naqvi, A. R. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.04.004 · Cited by 37
“However, transducing the activity of SAMHD1 is counteracted by Viral Protein X (VpX) which targets and degrades the protein, leading to the restoration of dNTP levels and allowing for HIV-1 replication [98,99].”
BackgroundLupia, T., Milia, M. G., Atzori, C., Gianella, S., Audagnotto, S., Imperiale, D., Mighetto, L., Pirriatore, V., Gregori, G., Lipani, F., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002442 · Cited by 37
“Dahl V. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.”
BackgroundInfluentialJin, S. W., Mwimanzi, F. M., Mann, J. K., Bwana, M., Lee, G. Q., Brumme, C. J., Hunt, P. W., Martin, J. N., Bangsberg, D. R., Ndung’u, T., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008813 · Cited by 34
Gao, Y., Ju, Y., Ren, X., Zhang, L., & Yin, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21886 · Cited by 37
“SAMHD1 is a myeloid-specific restriction factor, belonging to a group of closely related DNA hydrolases and nucleases with SAM domains and HD domains that prevents viral infection at an early stage of reverse transcription [17,18].”
BackgroundSafeguard against DNA sensing: the role of TREX1 in HIV-1 infection and autoimmune diseases
Hasan, M., & Yan, N. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00193 · Cited by 35
Illuminating the Role of Vpr in HIV Infection of Myeloid Cells
Nodder, S. B., & Gummuluru, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01606 · Cited by 38
“Vpx bridges SAMHD1 to the E3-ubiquitin ligase CUL4A-DDB1 DCAF (DCAFCRL4) leading to its polyubiquitination and proteasomal degradation (10, 11, 36).”
BackgroundInfluentialSAMHD1 Has Differential Impact on the Efficacies of HIV Nucleoside Reverse Transcriptase Inhibitors
Huber, A. D., Michailidis, E., Schultz, M. L., Ong, Y. T., Bloch, N., Puray‐Chavez, M., Leslie, M. D., Ji, J., Lucas, A. D., Kirby, K. A., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02745-14 · Cited by 33
The Dynamic Interplay between HIV-1, SAMHD1, and the Innate Antiviral Response
Antonucci, J. M., Gelais, C. S., & Wu, L. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01541 · Cited by 36
“SAMHD1 is constitutively expressed at various levels in all cell types and highly expressed in myeloid lineage and resting CD4+ T-cells (14, 15, 19).”
BackgroundInfluentialRao, S., Amorim, R., Niu, M., Breton, Y., Tremblay, M. J., & Mouland, A. J. (2019) · Retrovirology · doi:10.1186/s12977-019-0465-2 · Cited by 34
“SAMHD1 is a well-characterized HIV-1 restriction factor in macrophages and we expect that the MDMs depleted of SAMHD1 are more permissive to productive HIV-1 infection [47].”
BackgroundSAMHD1 Enhances Chikungunya and Zika Virus Replication in Human Skin Fibroblasts
Wichit, S., Hamel, R., Zanzoni, A., Diop, F., Cribier, A., Talignani, L., Diack, A., Ferraris, P., Liégeois, F., Urbach, S., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071695 · Cited by 34
Self-citationJames, C. D., Prabhakar, A. T., Otoa, R. O., Evans, M. R., Wang, X., Bristol, M. L., Zhang, K., Li, R., & Morgan, I. M. (2019) · mSphere · doi:10.1128/msphere.00448-19 · Cited by 33
“The HIV-2 encoded accessory factor Vpx, which is also found in closely related simian immunodeficiency virus (SIV) strains, degrades SAMHD1 through a proteasome-dependent mechanism (24).”
BackgroundSAMHD1 … and Viral Ways around It
Deutschmann, J., & Gramberg, T. (2021) · Viruses · doi:10.3390/v13030395 · Cited by 34
“In target cells, Vpx induces the proteasomal degradation of SAMHD1 by tying it to the ubiquitin–proteasome system [54,55].”
BackgroundYou Shall Not Pass: MX2 Proteins Are Versatile Viral Inhibitors
Betancor, G. (2023) · Vaccines · doi:10.3390/vaccines11050930 · Cited by 35
“SAMHD1 inhibits HIV-1 infection in macrophages, resting CD4+ T cells, and dendritic cells by reducing the level of dNTPs available for reverse transcription [87,88].”
BackgroundAntiretroviral restriction factors
Hatziioannou, T., & Bieniasz, P. D. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.007 · Cited by 33
Type I IFN – A blunt spear in fighting HIV-1 infection
Acchioni, C., Marsili, G., Perrotti, E., Remoli, A. L., Sgarbanti, M., & Battistini, A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.10.004 · Cited by 36
“Overcoming the SAMHD1mediated restriction by artificial addition of Vpx, [25,26] actually”
BackgroundVpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro
Norton, T. D., Miller, E. A., Bhardwaj, N., & Landau, N. R. (2015) · Gene Therapy · doi:10.1038/gt.2014.117 · Cited by 36
Marno, K. M., Ogunkolade, B.-W., Pade, C., Oliveira, N. M. M., O’Sullivan, E., & McKnight, Á. (2014) · Retrovirology · doi:10.1186/1742-4690-11-3 · Cited by 35
“Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, et al: SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates.”
InfluentialBlanchet, F. P., Stalder, R., Czubala, M., Lehmann, M., Rio, L., Mangeat, B., & Piguet, V. (2013) · Retrovirology · doi:10.1186/1742-4690-10-6 · Cited by 30
Deshiere, A., Joly-Beauparlant, C., Breton, Y., Ouellet, M., Raymond, F., Lodge, R., Barat, C., Roy, M.-A., Corbeil, J., & Tremblay, M. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-05566-9 · Cited by 33
Adaptation to the Interferon-Induced Antiviral State by Human and Simian Immunodeficiency Viruses
Bitzegeio, J., Sampias, M., Bieniasz, P. D., & Hatziioannou, T. (2013) · Journal of Virology · doi:10.1128/jvi.03219-12 · Cited by 32
“These results suggest that neither SAMHD1 nor any other potential Vpx target protein is responsible for the IFN- - induced restriction of HIV-1 and SIVMAC239 replication in unnatural host cells.”
BackgroundInfluentialTareen, S. U., Kelley-Clarke, B., Nicolai, C. J., Cassiano, L. A., Nelson, L. T., Slough, M. M., Vin, C. D., Odegard, J. M., Sloan, D. D., Van Hoeven, N., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2013.278 · Cited by 32
Metabolic profiling during HIV-1 and HIV-2 infection of primary human monocyte-derived macrophages
Hollenbaugh, J. A., Montero, C. M., Schinazi, R. F., Munger, J. C., & Kim, B. (2016) · Virology · doi:10.1016/j.virol.2016.01.023 · Cited by 32
“Several studies have reported that host sterile alpha motif (SAM) and histidine/aspartic acid (HD) domain protein 1 (SAMHD1) acts as a myeloid specific host anti-HIV/SIV restriction factor (Hrecka et al., 2011; Laguette et al., 2011).”
InfluentialGelais, C. S., Kim, S. H., Ding, L., Yount, J. S., Ivanov, D. N., Spearman, P. W., & Wu, L. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.753947 · Cited by 33
“SAMHD1 has been characterized as a viral restriction factor that blocks the replication of several retroviruses, including HIV-1, and DNA viruses in quiescent cells such as resting T cells, macrophages, and dendritic cells (2, 3, 11, 12).”
BackgroundT Cell Subsets in the Germinal Center: Lessons from the Macaque Model
Vaccari, M., & Franchini, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00348 · Cited by 37
“Recent work by Ruffin et al. showed that GC–TFH cells from LNs and tonsil obtained from chronically infected patients express low levels of the HIV-1 restriction factor SAMHD1 (98, 99).”
BackgroundPerez‐Zsolt, D., Martínez‐Picado, J., & Izquierdo‐Useros, N. (2019) · Viruses · doi:10.3390/v12010008 · Cited by 36
“The de-phosphorylated form of the host factor sterile alpha motif histidine-aspartate domain-containing protein 1 (SAMHD1) is the most potent restriction factor that limits HIV-1 infection in DCs [97] (Figure 2A, top).”
BackgroundHIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3
Manganaro, L., de Castro, E., Maestre, A. M., Olivieri, K. C., García‐Sastre, A., Fernández-Sesma, A., & Simon, V. R. (2015) · Journal of Virology · doi:10.1128/jvi.01596-15 · Cited by 36
DeLucia, M., Mehrens, J., Wu, Y. G., & Ahn, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.469007 · Cited by 32
“Vpx has been demonstrated to reprogram the CRL4 E3 ubiquitin ligase by binding DCAF1, a substrate receptor of the ligase (35–37), and recruiting SAMHD1 for proteasome-dependent degradation (2, 3, 20).”
BackgroundHeterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors
Mamede, J. I., Sitbon, M., Battini, J., & Courgnaud, V. (2013) · Retrovirology · doi:10.1186/1742-4690-10-77 · Cited by 35
Increased iron export by ferroportin induces restriction of HIV-1 infection in sickle cell disease
Kumari, N., Ammosova, T., Diaz, S. F., Lin, X., Niu, X., Ivanov, A. I., Jerebtsova, M., Dhawan, S., Oneal, P. A., & Nekhai, S. A. (2016) · Blood Advances · doi:10.1182/bloodadvances.2016000745 · Cited by 35
Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury
Li, H., Zhang, W., Zhong, F., Das, G. C., Xie, Y., Li, Z., Cai, W., Jiang, G., Choi, J. W., Sidani, M. A., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.07.023 · Cited by 32
Wacleche, V. S., Cattin, A., Goulet, J.-P., Gauchat, D., Gosselin, A., Cleret‐Buhot, A., Zhang, Y., Tremblay, C. L., Routy, J., & Ancuța, P. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018020123 · Cited by 36
Aso, H., Ito, J., Koyanagi, Y., & Sato, K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00429 · Cited by 33
“…Van Damme et al., 2008), MX2 (Goujon et al., 2013; Kane et al., 2013), SAM domain and HD domain-containing protein 1 (SAMHD1) (Hrecka et al., 2011; Laguette et al., 2011), and tripartite motif containing 5 (TRIM5) (Stremlau et al., 2004), TRIM56 (Kane et al., 2016), IFN induced transmembrane…”
BackgroundAntiviral factors and their counteraction by HIV-1: many uncovered and more to be discovered
Kmieć, D., & Kirchhoff, F. (2024) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjae005 · Cited by 33
“…the Benkirane and Skowronski laboratories showed that SAM domain and HD domain-containing protein 1 suppresses HIV-1 replication in some cell types by reducing the pool of available deoxynucle-oside triphosphates required for reverse transcription (Hrecka et al., 2011 ; Laguette et al., 2011 ).”
BackgroundViral Live‐Attenuated Vaccines (LAVs): Past and Future Directions
Tang, Y., Li, Y., Cai, X., & Yin, X. (2024) · Advanced Science · doi:10.1002/advs.202407241 · Cited by 44
Guo, H., Wei, W., Wei, Z., Liu, X., Evans, S. L., Yang, W., Wang, H., Guo, Y., Zhao, K., Zhou, J.-Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066201 · Cited by 31
Rodriguez-Plata, M. T., Urrutia, A., Cardinaud, S., Buzón, M. J., Izquierdo‐Useros, N., Prado, J. G., Puertas, M. C., Erkizia, I., Coulon, P.-G. A., Cedeño, S., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200267 · Cited by 33
HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells
Chauveau, L., Puigdomènech, I., Ayinde, D., Roesch, F., Porrot, F., Bruni, D., Visseaux, B., Descamps, D., & Schwartz, O. (2015) · Retrovirology · doi:10.1186/s12977-014-0131-7 · Cited by 31
“The restriction factor SAMHD1 blocks HIV replication by degrading intracellular dNTPs and HIV-1 RNA [31-37].”
BackgroundMethodInfluentialSelf-citationAntonucci, J. M., Kim, S., Gelais, C. S., Bonifati, S., Li, T.-W., Buzovetsky, O., Knecht, K. M., Duchon, A. A., Xiong, Y., Musier‐Forsyth, K., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00292-18 · Cited by 32
“Sterile alpha motif and HD domain-containing protein 1 (SAMHD1) is the only identified mammalian deoxynucleoside triphosphate triphosphohydrolase (dNTPase) (1, 2) with a well-characterized role in the downregulation of intracellular deoxynucleoside triphosphate (dNTP) levels (3), a mechanism by which SAMHD1 acts as a…”
BackgroundApolipoprotein E is an HIV-1-inducible inhibitor of viral production and infectivity in macrophages
Siddiqui, R., Suzu, S., Ueno, M., Nasser, H., Koba, R., Bhuyan, F., Noyori, O., Hamidi, S., Sheng, G., Yasuda-Inoue, M., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007372 · Cited by 35
Johnson, J. R., Crosby, D. C., Hultquist, J. F., Kurland, A. P., Adhikary, P., Li, D., Marlett, J. M., Swann, J., Hüttenhain, R., Verschueren, E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110690 · Cited by 34
Gifford, L. B., & Melikyan, G. B. (2024) · ACS Nano · doi:10.1021/acsnano.3c07678 · Cited by 34
Myeloid dendritic cells in HIV-1 infection
Derby, N. R., Martinelli, E., & Robbiani, M. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283499d63 · Cited by 31
Antagonism of SAMHD1 is actively maintained in natural infections of simian immunodeficiency virus
Spragg, C. J., & Emerman, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316839110 · Cited by 32
New insights into an X-traordinary viral protein
Schaller, T., Bauby, H., Hué, S., Malim, M. H., & Goujon, C. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00126 · Cited by 33
“Intriguingly, in contrast to what is observed in MDDCs, wildtype SAMHD1 from myeloid and plasmacytoid DCs (mDCs and pDCs, respectively), was shown to be resistant to Vpx-induced degradation (Bloch et al., 2014).”
BackgroundInfluentialThe Cytoplasmic Tail of Retroviral Envelope Glycoproteins
Tedbury, P. R., & Freed, E. O. (2014) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.10.009 · Cited by 33
Terol, M. J., Gazon, H., Lemasson, I., Dodon, M. D., Barbeau, B., Césaire, R., Mesnard, J.-M., & Péloponèse, J. (2017) · Leukemia · doi:10.1038/leu.2017.74 · Cited by 32
ISG15 Deficiency Enhances HIV-1 Infection by Accumulating Misfolded p53
Kuffour, E. O., König, R., Häussinger, D., Schulz, W. A., & Münk, C. (2019) · mBio · doi:10.1128/mbio.01342-19 · Cited by 32
Zahoor, M. A., Xue, G., Sato, H., & Aida, Y. (2015) · Virus Research · doi:10.1016/j.virusres.2015.06.017 · Cited by 35
Progress in Pseudotyping Lentiviral Vectors Towards Cell-Specific Gene Delivery In Vivo
Arduini, A., Katiyar, H., & Liang, C. (2025) · Viruses · doi:10.3390/v17060802 · Cited by 33
Identification and characterization of naturally occurring splice variants of SAMHD1
Welbourn, S., Miyagi, E., White, T. E., Diaz‐Griffero, F., & Strebel, K. (2012) · Retrovirology · doi:10.1186/1742-4690-9-86 · Cited by 30
SIV replication is directly downregulated by four antiviral miRNAs
Sisk, J. M., Witwer, K. W., Tarwater, P. M., & Clements, J. E. (2013) · Retrovirology · doi:10.1186/1742-4690-10-95 · Cited by 30
“These include, but are not limited to, TRIM5α [18,19], APOBEC3G [20,21], SAMHD1 [22,23] and miRNAs [24,25].”
BCA2/Rabring7 Interferes with HIV-1 Proviral Transcription by Enhancing the SUMOylation of IκBα
Colomer-Lluch, M., & Serra-Moreno, R. (2017) · Journal of Virology · doi:10.1128/jvi.02098-16 · Cited by 30
Viral Modulation of the DNA Damage Response and Innate Immunity: Two Sides of the Same Coin
Lopez, A., Doyle, R. N., Sandoval, C., Nisson, K., Yang, V. B., & Fregoso, O. I. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167327 · Cited by 33
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages
Pagani, I., Demela, P., Ghezzi, S., Vicenzi, E., Pizzato, M., & Poli, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063021 · Cited by 31
“In the case of HIV-2-restricted Vpx, midostaurin was identified as possessing both pro- and anti-viral effects in macrophages by, on the one hand, blocking the cell cycle in the G2/M phase, thereby preventing SAMHD1 phosphorylation and activation; on the other hand, in the absence of SAMHD1, midostaurin showed enhanci…”
BackgroundInfluentialRole of Siglecs in viral infections: A double-edged sword interaction
Regué, D. R., Resa‐Infante, P., Gallemí, M., Laguía, F., Muñiz-Trabudua, X., Muñoz‐Basagoiti, J., Perez‐Zsolt, D., Chojnacki, J., Benet, S., Clotet, B., et al. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101113 · Cited by 32
Animal models for studies of HIV-1 brain reservoirs
Waight, E. M., Zhang, C., Mathews, S., Kevadiya, B. D., Lloyd, K. C. K., Gendelman, H. E., Gorantla, S., Poluektova, L. Y., & Dash, P. K. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.5vmr0322-161r · Cited by 30
de Silva, S., Planelles, V., & Wu, L. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035385 · Cited by 37
“Similar to several CD4 T-cell lines [48], Hut/CCR5 cells do not express”
BackgroundResultAnalysis of Determinants in Filovirus Glycoproteins Required for Tetherin Antagonism
Gnirß, K., Fiedler, M., Krämer-Kühl, A., Bolduan, S., Mittler, E., Becker, S., Schindler, M., & Pöhlmann, S. (2014) · Viruses · doi:10.3390/v6041654 · Cited by 30
“Single restriction factors have been identified by screening approaches seeking to determine the molecular mechanism underlying a specific antiviral activity [3] [4] [5] [6] [7] .”
BackgroundLaplana, M., Carúz, A., Pineda, J. A., Puig, T., & Fibla, J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis685 · Cited by 30
Kodigepalli, K. M., Li, M., Liu, S., & Wu, L. J. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1261226 · Cited by 37
SAMHD1 deficient human monocytes autonomously trigger type I interferon
Martínez‐López, A., Martín-Fernández, M., Buta, S., Kim, B., Bogunovic, D., & Diaz‐Griffero, F. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.08.005 · Cited by 32
“…restricting HIV-1 infection of non-cycling cells such as macrophages, dendritic cells and resting CD4+ T cells (Arfi et al., 2008; Baldauf et al., 2012; Descours et al., 2012; Goujon et al., 2008, 2003; Goujon et al., 2007; Hrecka et al., 2011; Laguette et al., 2011; St Gelais et al., 2012).”
Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses
Becker, T., Le‐Trilling, V. T. K., & Trilling, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071636 · Cited by 31
“Well-known examples of viral exploitation of DDB1 and/or CRLs include the hepatitis B virus (HBV) protein HBx [84, [89] [90] [91] [92] , the HIV-1-and HIV-2-encoded protein Vpr [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] , HIV-2 Vpx [103] [104] [105] [106] [107] [108] [109] , parainfluenza virus (PIV) V prote…”
Johnson, J. S., Veaux, N. D., Rives, A. W., Lahaye, X., Lucas, S. Y., Pérot, B. P., Luka, M., Garcia-Paredes, V., Amon, L. M., Watters, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.054 · Cited by 32
“The major restriction factor in myeloid DCs is SAMHD1, an enzyme that exhibits phosphohydrolase activity and depletes the cellular pool of deoxyribonucleotide triphosphates (dNTPs) required for HIV reverse transcription (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundHIV-1 Persistence and Chronic Induction of Innate Immune Responses in Macrophages
Akiyama, H., & Gummuluru, S. (2020) · Viruses · doi:10.3390/v12070711 · Cited by 33
Exploring the potential of CAR-macrophage therapy
Shi, Y., Li, X., Dong, Y., Yuan, H., Wang, Y., & Yang, R. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123300 · Cited by 32
Gelais, C. S., Coleman, C. M., Wang, J., & Wu, L. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034521 · Cited by 33
“Nef-mediated suppression of T cell activation is a critical feature of non-pathogenic primate lentiviruses and HIV-2, whereas HIV- 1 Nef induces T cell activation and contributes to viral pathogenicity [54].”
BackgroundThe Role of Caveolin 1 in HIV Infection and Pathogenesis
Mergia, A. (2017) · Viruses · doi:10.3390/v9060129 · Cited by 30
“In nonhuman primate models, PAH is observed with the infection of chimeric SIV containing the HIV Nef (SHIV), while the control SIV shows no PAH, suggesting a role for Nef in PAH pathology [263].”
BackgroundInfluentialRole of the Ubiquitin Proteasome System (UPS) in the HIV-1 Life Cycle
Rojas, V. K., & Park, I.-W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122984 · Cited by 30
Nazitto, R., Amon, L. M., Mast, F. D., Aitchison, J. D., Aderem, A. A., Johnson, J. S., & Diercks, A. H. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001235 · Cited by 33
Kapoor-Vazirani, P., Rath, S. K., Liu, X., Shu, Z., Bowen, N. E., Chen, Y., Haji‐Seyed‐Javadi, R., Daddacha, W. B., Minten, E. V., Danelia, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34578-x · Cited by 33
Novel factors interfering with human immunodeficiency virus‐type 1 replication in vivo and in vitro
Vicenzi, E., & Poli, G. (2013) · Tissue Antigens · doi:10.1111/tan.12047 · Cited by 47
Ramirez, P. W., DePaula-Silva, A. B., Szaniawski, M. A., Barker, E., Bosque, A., & Planelles, V. (2015) · Retrovirology · doi:10.1186/s12977-015-0192-2 · Cited by 29
“Similarly, the HIV-2 accessory protein Vpx relies on a CRL4 complex to degrade the restriction factor SAMHD1 [6, 7].”
BackgroundG3BP1 restricts HIV-1 replication in macrophages and T-cells by sequestering viral RNA
Jiménez, V. C., Martínez, F. O., Booiman, T., van Dort, K. A., van de Klundert, M. A. A., Gordon, S., Geijtenbeek, T. B. H., & Kootstra, N. A. (2015) · Virology · doi:10.1016/j.virol.2015.09.007 · Cited by 33
“, 2013) and SAMHD1 (Hrecka et al., 2011; Laguette et al., 2011; Lahouassaet al., 2012), or MCPIP1 in activated CD4þ T cells (Liu”
BackgroundA Mechanistic Overview of Dendritic Cell-Mediated HIV-1 Trans Infection: The Story So Far
Kijewski, S. D. G., & Gummuluru, S. (2015) · Future Virology · doi:10.2217/fvl.15.2 · Cited by 36
N -Linked Glycosylation Protects Gammaretroviruses against Deamination by APOBEC3 Proteins
Gerpe, M. C. R., Renner, T. M., Bélanger, K., Lam, C., Aydin, H., & Langlois, M. (2014) · Journal of Virology · doi:10.1128/jvi.03330-14 · Cited by 31
“(6, 7), SAMHD1 is defeated by Vpx (8, 9), A3 (A3F, A3G, A3D,”
Sun, J., Schaaf, K., Duverger, A. E., Wolschendorf, F., Speer, A., Wagner, F., Niederweis, M., & Kutsch, O. (2016) · Oncotarget · doi:10.18632/oncotarget.8190 · Cited by 29
“Macrophage infection models for Mtb studies have extensively utilized THP-1 cells [37-39], which have also been widely used in HIV-1 research [40-42], and proven highly useful in the discovery of macrophage restriction factors to HIV-1 [43, 44].”
MethodLentiviral vector interactions with the host cell
Borsotti, C., Borroni, E., & Follenzi, A. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.08.016 · Cited by 30
Wang, H., Guo, H., Su, J., Rui, Y., Zheng, W., Gao, W., Zhang, W., Li, Z., Liu, G., Markham, R. B., et al. (2017) · Journal of Virology · doi:10.1128/jvi.00225-17 · Cited by 29
“SAMHD1 is a specific inhibitor of HIV/SIV infection in myeloid cells (53, 71).”
BackgroundSAMHD1 enhances nucleoside-analogue efficacy against HIV-1 in myeloid cells
Ordonez, P., Kunzelmann, S., Groom, H. C. T., Yap, M. W., Weising, S., Meier, C., Bishop, K. N., Taylor, I. A., & Stoye, J. P. (2017) · Scientific Reports · doi:10.1038/srep42824 · Cited by 30
A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis
Wing, P. A. C., Davenne, T., Wettengel, J. M., Lai, A. G., Zhuang, X., Chakraborty, A., D’Arienzo, V., Kramer, C., Ko, C., Harris, J. M., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900355 · Cited by 31
“Viruses generally evolve to evade or counteract host restriction factors, for example, lentiviral accessory proteins Vpx and Vpr target SAMHD1 for proteasomal degradation via the E3 cellular ubiquitin ligase complex (Laguette et al, 2011; Lim et al, 2012).”
Husain, A., Xu, J., Fujii, H., Nakata, M., Kobayashi, M., Wang, J. O., Rehwinkel, J., Honjo, T., & Begum, N. A. (2020) · The EMBO Journal · doi:10.15252/embj.2019102931 · Cited by 31
“…of SAMHD1, a dNTP triphosphohydrolase, restricts viral infection, particularly in non-dividing cells, by depleting cellular dNTPs which are essential for viral reverse transcription as well as replication (Hrecka et al , 2011; Laguette et al , 2011; Baldauf et al , 2012; Lahouassa et al , 2012).”
Ou, C., Wang, Q., Zhang, Y., Kong, W., Zhang, S., Yu, Y. P., Ma, J., Liu, X., & Kong, X. (2017) · Virology Journal · doi:10.1186/s12985-017-0757-x · Cited by 40
Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission?
Sumner, R. P., Thorne, L., Fink, D., Khan, H., Milne, R. S. B., & Towers, G. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01246 · Cited by 29
“Mutations of key residues in the HD region cause SAMHD1 to lose its ability to restrict HIV-1 (124).”
BackgroundNguyen, H., Gazy, N., & Venketaraman, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176148 · Cited by 23
Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses
Gaba, A., Flath, B., & Chelico, L. (2021) · Viruses · doi:10.3390/v13061084 · Cited by 31
“suppressed by Vpx which is produced from HIV-2 and SIV, but not HIV-1 [18,19].”
BackgroundThe Interplay Among HIV, LINE-1, and the Interferon Signaling System
Zhao, X., Zhao, Y., Du, J., Gao, P., & Zhao, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732775 · Cited by 36
“In addition, SAMHD1 is a potent HIV suppressor in non-dividing cells such as macrophages and dendritic cells (29, 30).”
BackgroundEfficient delivery of lentiviral vectors into resting human CD4 T cells
Geng, X., Doitsh, G., Yang, Z., Galloway, N. L. K., & Greene, W. C. (2014) · Gene Therapy · doi:10.1038/gt.2014.5 · Cited by 29
Guney, M. H., Nagalekshmi, K., McCauley, S. M., Carbone, C., Aydemir, Ö., & Luban, J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2404349121 · Cited by 30
“The Vpx-containing SIV-VLPs were added to these cultures to overcome a SAMHD1 block to lentiviral transduction (117, 118).”
Power, C., Hui, E., Vivithanaporn, P., Acharjee, S., & Polyak, M. J. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9310-7 · Cited by 28
“ubiquitin ligase complex leads to the proteosomal degradation of the inhibitory factor, SAMHD1 (Laguette et al. 2011; Srivastava et al. 2008).”
Background
Metadata
- Authors
- Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Laguette, Nadine
- Benkirane, Monsef
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7353
- Pages
- 654-657
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3595993
- OpenAlex
- W2069554621
- Cited by
- 1,511
- References
- 27
- Citations by year
- 2026: 45 · 2025: 60 · 2024: 67 · 2023: 67 · 2022: 84 · 2021: 72 · 2020: 82 · 2019: 113 · 2018: 113 · 2017: 109 · 2016: 114 · 2015: 118 · 2014: 134 · 2013: 159 · 2012: 131
- FWCI
- 58.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- SAMHD1, HIV-1 restriction factors, Vpx, dendritic cells, myeloid cells, Aicardi-Goutières syndrome, proteasomal degradation, HIV-1 replication, viral DNA accumulation, phosphohydrolase activity, interferon response, HIV-2, simian immunodeficiency virus
- MeSH terms
- SAM Domain and HD Domain-Containing Protein 1, Cell Line, Dendritic Cells, DNA, Viral, HeLa Cells, Humans, Virus Replication, HIV-1, HIV Infections, U937 Cells, Monomeric GTP-Binding Proteins, Gene Silencing, Myeloid Cells, Proteasome Endopeptidase Complex, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.